Revenue: $4,495.245M, YoY +13.43%, QoQ +4.94%. Gross Profit: $4,080.662M, YoY +14.22%, QoQ +5.58%. Operating Income: $521.688M, YoY +35.80%, QoQ +4.28%. Net Income: $372.957M, YoY +44.16%, QoQ +5.59%. EPS (diluted): $5.74, YoY +49.10%, QoQ +5.65%. Gross Margin: 90.78%, Operating Margin: 11.61%, Pretax Margin: 11.15%, Net Margin: 8.30%. EBITDA: $699.377M, EBITDA Margin (EBITDA/Revenue): ~15.56%. Cash Flow: Operating Cash Flow per Share $20.04; Free Cash Flow per Share $8.64; Cash per Share $1.754; Dividend Payout 10.4% of earnings. Liquidity/Leverage: Current Ratio 1.031x; Quick Ratio 0.960x; Cash Ratio 0.036x; Debt Ratio 0.333x; Debt to Equity 0.707x; Long-Term Debt to Capitalization 0.353x; Interest Coverage 13.57x. Activity: DSO 51.76 days; DIO 49.20 days; DPO 506.33 days; Cash Conversion Cycle (CCC) -405.37 days (negative CCC driven by payables). Valuation context: P/E ~8.82x, P/B ~1.82x, EV/EBITDA ~25.96x, Dividend Yield ~0.30%. YoY/QoQ revenue and earnings growth highlight improving profitability and cash generation against a backdrop of strong demand for hospital-based services.